Article

Oral Wegovy Broadens Care Continuum Across First-Time GLP-Starters, High Cardiometabolic Burden GLP-Switchers, and Medicare-Age Patients

2026-07-14

Abstract excerpt

Oral Wegovy (semaglutide weight-loss pill) initiation now spans two clinically distinct real-world entry states: “GLP-starters” without recent GLP-1 receptor agonist (GLP-1RA) prescriptions and “GLP-switchers” with a recent record for a different injectable or oral incretin therapy. Using a large federated U.S. electronic health record network, we studied the five-year history prior to Wegovy pill initiation. Of 8...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3e6c55e2-f5a4-592d-aff8-5bd9452dbf81
DOI: 10.20944/preprints202607.0935.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Oral Wegovy Broadens Care Continuum Across First-Time GLP-Starters, High Cardiometabolic Burden GLP-Switchers, and Medicare-Age PatientsDOI 10.20944/preprints202607.0935.v1Read

Auditable LLM Curation of Clinical Notes Refines GLP-1 Initiation, Persistence Ascertainment and Compounding Use Beyond Prescription RecordsSemantic proximity Read

Greater lean-body-mass decline with tirzepatide than semaglutide in routine care, revealed by body-composition digital phenotypingSemantic proximity Read

Legacy neuropsychiatric benefit after semaglutide is linked to maximum achieved dose and independent of the maximum weight lostSemantic proximity Read

Phenome-wide analysis of downstream health outcomes following second-line antidiabetic agent prescriptions in All of Us.Semantic proximity Read

GLP Medications and Severe Post-COVID-19 Outcomes Among Individuals with Type 2 Diabetes MellitusSemantic proximity Read

Pharmacogenomics of GLP-1 Receptor Agonists: Precision Medicine in the Age of Ozempic and MounjaroSemantic proximity Read

Clinical efficacy landscaping in genetic obesity: A meta-analysis in Prader Willi syndrome (PWS)Semantic proximity Read

Current status of anti-obesity medications and performance, an EHR based surveySemantic proximity Read

Precision obesity medicine: A phenotype-guided framework for pharmacologic therapy across the lifespan.Semantic proximity Read

Oral Health Outcomes with GLP1 Receptor Agonists Compared with Other Metabolic InterventionsSemantic proximity Read

Real-World Effectiveness, Safety, and Use Patterns of GLP-1 Receptor Agonists in Obesity and Type 2 Diabetes: A Nationwide Multicentre Community Pharmacy StudySemantic proximity Read